None
Quote | Harpoon Therapeutics Inc. (NYSE:HARP)
Last: | $ |
---|---|
Change Percent: | 1.94% |
Open: | $16.06 |
Close: | $16.29 |
High: | $17.2399 |
Low: | $16.06 |
Volume: | 102,238 |
Last Trade Date Time: | 02/12/2020 04:40:18 pm |
News | Harpoon Therapeutics Inc. (NYSE:HARP)
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...
Message Board Posts | Harpoon Therapeutics Inc. (NYSE:HARP)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $HARP 21% v1,6M c1.37 f33,228M H1.45 ML.74 | znewcar1 | investorshangout | 02/07/2023 11:15:51 PM |
znewcar1: $HARP 25% v2,2M c1.18 f33,228M H1.19 ML1.19 | znewcar1 | investorshangout | 01/27/2023 9:50:37 PM |
znewcar1: $HARP 23% v594K c1.159 f33,228M H1.19 | znewcar1 | investorshangout | 01/27/2023 3:32:14 PM |
znewcar1: $HARP 22% v99,2M c1.41 f33,228M H3.3548 Laft1.32 | znewcar1 | investorshangout | 12/12/2022 11:06:09 PM |
znewcar1: $HARP 20% v1,5M c1.15 f33,2MH1.27 ML.6628 S1? | znewcar1 | investorshangout | 12/10/2022 3:42:46 AM |
News, Short Squeeze, Breakout and More Instantly...
Harpoon Therapeutics Inc. Company Name:
HARP Stock Symbol:
NYSE Market:
Harpoon Therapeutics Inc. Website:
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
2024-02-14 02:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Merck & Co Inc’s (NYSE:MRK) fourth-quarter 2023 sales reached $14.63 billion, up 6% Y/Y, beating the consensus of $14.50 billio...